MedPath

The Role of Lidocaine Spray in Reducing Pain During Intrauterine Device Application

Not Applicable
Completed
Conditions
Intrauterine Device Migration
Pain
Interventions
Drug: Lidocain spray
Registration Number
NCT07155785
Lead Sponsor
Kanuni Sultan Suleyman Training and Research Hospital
Brief Summary

Investigators aimed to investigate the effectiveness of the use of local lidocaine spray application to make routine intrauterine intrauterine device application more painless.

Detailed Description

As a standard, no anaesthesia is applied to the patient during intrauterine device application in outpatient clinic conditions. Patients can usually tolerate the procedure even if there is minimal pain and discomfort. In patients with low pain tolerance, the procedure can be terminated before the application can be performed and the application can be repeated under local or general anaesthesia. Local anaesthetic sprays are routinely and comfortably used in episiotomy repair, upper gastrointestinal tract endoscopy and intraoral procedures. In our study, investigators aimed to demonstrate the efficacy of local spray anaesthesia without side effects for the relief of pain that occurs in some patients during intrauterine device application by comparing it with placebo.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
90
Inclusion Criteria
  • 18-45 years old patient who comes to have an intrauterine device inserted voluntarily
  • The patient who gave consent to participate in the study
Exclusion Criteria
  • Patients who cannot have an intrauterine device because of fibroids or cervical stenosis
  • Patient who did not want to participate in the study

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Active groupLidocain sprayThis group received lidocaine spray during intrauterine device application.
Placebo groupLidocain sprayThis group received saline spray during intrauterine device application.
Primary Outcome Measures
NameTimeMethod
Pain component1 hour

Reduction of the pain felt during application of the intrauterine device

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Istanbul Medeniyet University

Istanbul, Turkey (Türkiye)

Istanbul Medeniyet University
Istanbul, Turkey (Türkiye)

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.